News for 'Sun Pharmaceuticals'

IPOs: India First, US Second, China Third

IPOs: India First, US Second, China Third

Rediff.com28 Sep 2024

India topped the APAC region with 227 transactions in the first eight months of CY24. The US was second with 133 deals while China ranked third with 69 transactions.

Scientists who decoded protein structures win Chemistry Nobel

Scientists who decoded protein structures win Chemistry Nobel

Rediff.com9 Oct 2024

The 2024 Nobel Prize in Chemistry has been awarded to David Baker, Demis Hassabis, and John M Jumper, the Royal Swedish Academy of Sciences announced on Wednesday.

'Workplace safety key to get more women in labour force'

'Workplace safety key to get more women in labour force'

Rediff.com27 Aug 2024

International Monetary Fund (IMF) Deputy Managing Director (MD) Gita Gopinath has condemned the "terrible and disturbing" incident of rape and murder of a trainee doctor in Kolkata. "Personally, it is terrible to have any event of this kind. It is disturbing," she told Business Standard in New Delhi.

Stock markets marginally up in volatile trade ahead of US Fed chief's speech

Stock markets marginally up in volatile trade ahead of US Fed chief's speech

Rediff.com23 Aug 2024

From the Sensex pack, Tata Motors, Sun Pharmaceutical, Bharti Airtel, Bajaj Finserv, ICICI Bank, Mahindra & Mahindra and JSW Steel were the gainers. Tech Mahindra, HCL Technologies, Asian Paints, Titan, Infosys, State Bank of India, Tata Consultancy Services and HDFC Bank were the laggards.

India flagged concerns with Russia over non-tariff barriers: Commerce secy

India flagged concerns with Russia over non-tariff barriers: Commerce secy

Rediff.com16 Jul 2024

India has flagged concerns over non-tariff barriers (NTBs) faced by its exporters with the Russian government, commerce secretary Sunil Barthwal said on Monday. NTBs faced by Indian exporters are mainly in sectors such as marine products and pharmaceuticals.

Govt may overhaul PLI schemes: Quarterly incentive payments on the table

Govt may overhaul PLI schemes: Quarterly incentive payments on the table

Rediff.com28 Jun 2024

To burnish production-linked incentive (PLI) schemes, the government is considering an overhaul of some of them relating to sectors such as textiles and pharma, and making incentive payments quarterly, officials in the know said. In a bid to cut the delay in processing incentive claims, the government is looking at switching to a quarterly disbursement of incentives. Currently, in most schemes, incentives are annual.

DPharm Vs BPharm: Which Is Better For A Career In Pharmacy?

DPharm Vs BPharm: Which Is Better For A Career In Pharmacy?

Rediff.com4 Aug 2024

To pursue a job, DPharm candidates must complete two years of coursework, three months of hospital training, and then pass the exit exam. However, BPharm graduates can pursue a job right after completing their four-year course, informs rediffGURU Dr Nagarajan JSK.

Why Is Maharashtra An Underperformer?

Why Is Maharashtra An Underperformer?

Rediff.com23 Nov 2024

'Why has Maharashtra slipped up over the past couple of decades?' 'Not only is this question critical for residents of the state, but given that it accounts for 14% of India's GDP, a faster-growing Maharashtra implies a faster-growing India as well, point out Shishir Gupta and Rishita Sachdeva.

'Real growth and opportunity are going to come from GLP-1'

'Real growth and opportunity are going to come from GLP-1'

Rediff.com21 Aug 2024

'It is not just the US and European opportunity, but it is a huge global opportunity.'

IPO Boom Fuel Investment Bankers' Fortunes

IPO Boom Fuel Investment Bankers' Fortunes

Rediff.com21 Aug 2024

So far this year, bankers have earned Rs 1,226 crore for handling 45 IPOs, which together mobilised Rs 48,363 crore.

Will Modi Achieve A Cease Fire In Ukraine?

Will Modi Achieve A Cease Fire In Ukraine?

Rediff.com21 Aug 2024

Ukraine is currently in the middle of a strategic offensive into Russia's Kursk region.

Promoter dilution in small, midcaps surges

Promoter dilution in small, midcaps surges

Rediff.com4 Oct 2024

The controlling shareholders of smaller and mid-sized companies are reducing their stakes at levels seldom seen since the 2008 global financial crisis. Over 20 per cent of companies listed on BSE MidCap and BSE SmallCap have seen a decline in promoter holdings for five consecutive quarters, reveals data from DSP Mutual Fund, shared with Business Standard. In the latest June quarter, the figure stood at 22.6 per cent.

185 Indians In $1 Billion Club

185 Indians In $1 Billion Club

Rediff.com3 Sep 2024

The combined wealth of India's dollar billionaires is now equivalent to 33.81 per cent of India's nominal GDP.

Stock markets rise on gains in Tata Motors, HDFC Bank

Stock markets rise on gains in Tata Motors, HDFC Bank

Rediff.com30 Jul 2024

From the Sensex pack, Tata Motors, NTPC, Bajaj Finserv, Power Grid Corp, Titan, Asian Paints, IndusInd Bank, Maruti Suzuki India and Tata Steel were among the biggest gainers. Sun Pharmaceuticals, ITC, Hindustan Unilever, Bharti Airtel, UltraTech Cement and Reliance Industries were among the laggards.

No timeline on Ukraine war, says Putin; appreciates Modi

No timeline on Ukraine war, says Putin; appreciates Modi

Rediff.com19 Oct 2024

Putin said that the Indian leader had "aptly" noted that it is "not an anti-western one but a non-western one".

Pharma cos okay with QR codes to combat counterfeit drugs

Pharma cos okay with QR codes to combat counterfeit drugs

Rediff.com19 Jul 2024

As the Drugs Controller General of India (DCGI) is set to crack down on companies to ensure compliance with printing QR codes on top-selling brands to curb counterfeiting, top pharma companies say they welcome the regulator's mandate and that they are on track. They also view it as a positive step to ensure patient safety. Sheetal Arora, CEO of Mankind Pharmaceuticals, which has already adopted QR codes in 20 of their products, stated: "We strongly advocate for mandatory implementation of barcodes and QR codes on medicines as this initiative will not only protect patients but also strengthen the integrity of our healthcare system by reducing circulation of counterfeit drugs."

Putin invites Palestine Prez Abbas to BRICS summit; Modi to attend

Putin invites Palestine Prez Abbas to BRICS summit; Modi to attend

Rediff.com19 Oct 2024

Putin expressed concern over the situation in Gaza, and said Palestinian President Mahmoud Abbas has been invited to BRICS events.

Sensex, Nifty rise on buying in banking stocks

Sensex, Nifty rise on buying in banking stocks

Rediff.com10 Oct 2024

Equity benchmark indices Sensex and Nifty settled higher on Thursday, powered by a rally in banking and power stocks amid a largely firm trend in global markets. The stock markets mostly traded range-bound in the absence of any major trigger and persistent foreign capital outflows, traders said. The 30-share BSE Sensex rose 144.31 points, or 0.18 per cent, to settle at 81,611.41.

With Rs 11.6 lakh cr wealth, Adani replaces Ambani as India's richest

With Rs 11.6 lakh cr wealth, Adani replaces Ambani as India's richest

Rediff.com29 Aug 2024

Recouping the dent caused by the Hindenburg Research report, Gautam Adani's networth shot up 95 per cent to Rs 11.6 lakh crore last year, which helped him replace Mukesh Ambani to become the richest Indian, a report said on Thursday. Reliance Industries chairman and managing director Ambani's overall networth increased by 25 per cent to Rs 10.14 lakh crore, as per the 2024 Hurun India Rich List. In 2023's report, Adani's wealth declined by 57 per cent to Rs 4.74 lakh crore, and Ambani was way ahead with a fortune of Rs 8.08 lakh crore.

AstraZeneca reaffirms Covid vaccine safety amid rare TTS concerns

AstraZeneca reaffirms Covid vaccine safety amid rare TTS concerns

Rediff.com1 May 2024

Despite these rare occurrences, the pharmaceutical company maintains that extensive clinical trial data and real-world evidence consistently support the vaccine's safety and efficacy.

Sensex, Nifty hit fresh lifetime highs on gains in ICICI Bank, Infosys shares

Sensex, Nifty hit fresh lifetime highs on gains in ICICI Bank, Infosys shares

Rediff.com4 Jul 2024

Among the Sensex pack, HCL Technologies, ICICI Bank, Tata Motors, Sun Pharmaceuticals, Tata Consultancy Services, Infosys, Kotak Mahindra Bank and Mahindra and Mahindra were the gainers. In contrast, HDFC Bank, Bajaj Finance, Larsen & Toubro, Tech Mahindra, UltraTech Cement and IndusInd Bank were among the laggards.

MNCs look towards India for a booster dose

MNCs look towards India for a booster dose

Rediff.com1 Apr 2024

In recent months, several pharma multinational corporations (MNCs) are increasingly turning to Indian companies to expand market reach in the country's pharmaceuticals sector. Sanofi's partnerships with Dr Reddy's, Cipla, and Emcure, AstraZeneca and Mankind Pharma - teaming up for asthma medication distribution - are a few instances of this trend. This strategy allows MNCs to leverage established Indian networks and reach a wider audience. Indian companies also benefit from global brands and expertise, say analysts.

Sensex slips below 80K; Nifty scales new high

Sensex slips below 80K; Nifty scales new high

Rediff.com5 Jul 2024

Among the 30-share Sensex pack, State Bank of India, Reliance Industries, Hindustan Unilever, NTPC, Larsen & Toubro, Nestle India, Power Grid, ITC, JSW Steel and Sun Pharmaceuticals were the major gainers. On the other hand, HDFC Bank, Titan, Mahindra & Mahindra, IndusInd Bank, UltraTech Cement, Tata Motors, HCL Technologies and Asian Paints were among the laggards.

'Ladakh Made The World Wary Of China'

'Ladakh Made The World Wary Of China'

Rediff.com7 Nov 2024

'While my generation carries with it the memory of the Chinese perfidy of 1962, this generation will carry the memory of Chinese perfidy in Galwan.'

'Nifty Pullback Needs To Be Taken In Stride'

'Nifty Pullback Needs To Be Taken In Stride'

Rediff.com22 Oct 2024

'The biggest near-term risk to Indian equities is the outflow of investments to China as tactical trades by foreign investors.'

Israel conflict unlikely to impact trade of pharma firms

Israel conflict unlikely to impact trade of pharma firms

Rediff.com12 Oct 2023

Indian pharmaceutical firms foresee minimal disruptions in trade with Israel despite escalating regional tensions. Rising crude prices and export shipping insurance premiums have raised concerns, but the pharmaceutical sector remains optimistic. Pharmaceutical exports from India to Israel in FY 2020-21 amounted to $32.5 million, which represents only a minor segment of India's overall pharma exports.

GST Gamed For Rs 81,875 cr, Finds Report

GST Gamed For Rs 81,875 cr, Finds Report

Rediff.com16 Sep 2024

The highest-ever goods and services tax (GST) evasion has been done by the online money gaming industry.

Zelenskyy explains war situation, Modi says India willing to help

Zelenskyy explains war situation, Modi says India willing to help

Rediff.com24 Aug 2024

Ukraine and Russia need to engage with each other to find a solution to the ongoing conflict between them, India said on Friday after Prime Minister Narendra Modi held wide-ranging talks with President Volodymyr Zelenskyy in Kyiv under the shadow of the raging war.

17 persons killed, 33 hurt in Andhra pharma unit fire

17 persons killed, 33 hurt in Andhra pharma unit fire

Rediff.com22 Aug 2024

Harrowing scenes unfolded at the SEZ where the fire ripped through the pharma company. Injured workers with torn clothes and bleeding injuries were seen being shifted to hospitals in ambulances.

Listed firms log record operating cash flow of Rs 11.1 trn in FY24

Listed firms log record operating cash flow of Rs 11.1 trn in FY24

Rediff.com2 Oct 2024

Indian companies are generating more cash than ever. The net cash flow from listed firms' operations hit a new high of Rs 11.1 trillion in financial year 2023-24 (FY24), crossing the Rs 10-trillion mark for the first time, according to the Centre for Monitoring Indian Economy (CMIE) data going back to 1990-91. The FY24 figure represents a 19.3 per cent jump over the previous year, even as quite a few companies are yet to release their numbers.

Indian pharmaceutical M&As see unhealthy decline

Indian pharmaceutical M&As see unhealthy decline

Rediff.com4 Apr 2008

While the April to September period (H1) saw as many as eight major deals worth over Rs 5,000 crore (Rs 50 billion), the second half of the year saw a sharp drop in the value of such deals to about Rs 1,500 crore (Rs 15 billion). Though the number of deals in H1 and H2 is almost the same, the sharp decline in value in the second half indicates a clear change in outlook and strategy of companies, say industry experts.

High-level delegation of US pension funds to visit India next week

High-level delegation of US pension funds to visit India next week

Rediff.com6 Sep 2024

A delegation of high-level executives from US public pension funds (non-profit and government sectors) is visiting India next week to assess and familiarise themselves with the investment opportunities in the country. These executives belong to various American states and cumulatively represent $1.8 trillion in assets under management (AUM) invested across the US and global markets. The United States (US) mission to India, which includes its embassy and consulates and the Department of Treasury, along with India's Ministry of Finance and the National Investment and Infrastructure Fund (NIIF), is hosting the delegation.

Subhash Dandekar: The man who brought colours to artists and students!

Subhash Dandekar: The man who brought colours to artists and students!

Rediff.com17 Jul 2024

Subhash Dandekar, chairman emeritus of Kokuyo Camlin and the man known for bringing colours to artists as well as students in the country, passed away on Monday at 85.

Markets Expected To Remain Volatile

Markets Expected To Remain Volatile

Rediff.com4 Oct 2024

'As the markets are expected to remain jittery in the near term, we advise investors to use this opportunity to enter quality largecaps from a long-term perspective.'

India To Fast-Track Visas For Chinese Nationals

India To Fast-Track Visas For Chinese Nationals

Rediff.com8 Aug 2024

The new guidelines, effective from August 1, aim to expedite visa approvals for nationals from China and other countries sharing land borders with India.

Modiji Blesses Anant-Radhika

Modiji Blesses Anant-Radhika

Rediff.com14 Jul 2024

Prime Minister Narendra D Modi on Saturday blessed the newly wed couple Anant Ambani and Radhika Merchant after their wedding that was attended by global celebrities, business tycoons and politicians.

Is A Toxic Work Culture Affecting You?

Is A Toxic Work Culture Affecting You?

Rediff.com20 Sep 2024

"There is a limit when it comes to tolerating abusive behaviour or working styles. Many (employees) find ways to quit," says career coach and rediffGURU Pradeep Pramanik.

AI Disruption Is REAL & Happening FAST!

AI Disruption Is REAL & Happening FAST!

Rediff.com28 Aug 2024

When AI is used to enhance operational efficiency, businesses can deliver the same product or service but with improved quality, faster, or even at a reduced cost

Emami has built itself through acquisition, but...

Emami has built itself through acquisition, but...

Rediff.com8 Oct 2024

Two young men jostle in a rickshaw as it clatters along a narrow, bustling lane of North Kolkata, each with a leg dangling over the side of the vehicle, a bulging sack of cosmetics nestled between them. The protagonists here are the founders of Emami - Radhe Shyam Agarwal and Radhe Shyam Goenka - childhood friends who gave up cushy corporate jobs to build a fast-moving consumer goods (FMCG) company. From a 200-square-foot rented space on Muktaram Babu Street in North Kolkata, brand Emami stepped into the competitive world of FMCG 50 years back, armed with just three products: Vanishing cream, talcum powder, and cold cream.

'Always Treat China With Caution'

'Always Treat China With Caution'

Rediff.com7 Nov 2024

'Given China's past behaviour and their territorial claims, should we be sceptical regarding China's willingness to adhere to these agreements fully? The answer is yes.' 'As Ronald Reagan famously said in the context of the SALT talks, 'Trust, but verify!' India should also do the same.' 'This has already begun with foot patrolling, drones, satellite imagery and so on. India's military deployment did mirror China's and will continue to do so in the future.'